Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 276-038-9 | CAS number: 71808-53-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Both the acute oral tests available on C12-18-alkylbis(hydroxyethyl)methyl, chloride (CAS no 71808-53-2) indicates GHS classification as acute oral toxicity category 4 (LD50 between 300 and 2000 mg/kg). No data is available on acute toxicity via inhalation or dermal route.
The newest oral LD50 study on C12-18-alkylbis(hydroxyethyl)methyl, chloride (CAS no 71808-53-2) has reliability rating 2 and is performed according to the US guideline on Consumer Product Safety Commission 16 CFR 1500, with some modifications. The reason for the reliability rating 2 is that the study was performed pre-GLP in 1981 and the test is reported in a limited report. No specific certificate of analysis or information on batch is included in the report. The result from this study is considered to be reliable, since the product tested has not changed significantly in its composition since the testing was carried out. Therefore the results are considered valid for the current manufactured C12-18-alkylbis(hydroxyethyl)methyl, chloride (CAS no 71808-53-2) and the result will be used for classification of the substance.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1981
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Inadequate study details and results (2 page service report);
- Qualifier:
- according to guideline
- Guideline:
- other: Consumer Product Safety Commission 16 CFR 1500
- Deviations:
- yes
- Remarks:
- Only 5 animals per group
- GLP compliance:
- no
- Test type:
- standard acute method
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Five male SpragueDawley derived albino rats from Hilltop Lab Animals, Inc., weight ranging from 200 to 265 grams.
Food was witheld from the rats for approximately 18 hours prior to dosing. Following dosing, food consisting of PURINA LABORATORY CHOW and
water were available ad libitum. The rats were housed in groups in stainless steel wire mesh cages suspended above the droppings. The animals were housed under a 12-hour light/12-hour dark cycle. The rats were acclimated to the laboratory at least seven days prior to dosing and were
individually identified by numbered ear tags and tail marks with permanent ink. - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- The test sample was administered by esophageal intubation to five groups, each composed of five male Sprague-Dawley derived albino rats from
Hilltop Lab Animals, Inc., weight ranging from 200 to 265 grams. Four groups were treated on April 1, 1981, and the fifth group was treated on April 8, 1981. The sample was administered undiluted at dosage levels of 0.464, 1.00, 2.15, 4.64, and 10.0 grams per kilogram of body weight using an
average density value of 1.036 g/ml for administration on a sample volume basis. - Doses:
- 0.464, 1.00, 2.15, 4.64, and 10.0 grams per kilogram of body weight
- No. of animals per sex per dose:
- 5
- Details on study design:
- All animals were observed closely for gross signs of systemic toxicity and mortality at one and one-half to two hours, three and three-quarter to four and one-quarter hours, and give and one-half to six hours post administration during the day of dosing, and at least once daily thereafter for a
total of 14 days. Gross necropsies were performed on the animals that died. At the end of the 14-day observation period the surviving rats were
weighed, sacrificed by C02 inhalation and gross necropsies were performed. Statittical analysis of the mortality data was by the moving average
method. - Statistics:
- moving average method
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 1.71 other: g/kg bw
- 95% CL:
- 1.26 - 2.33
- Clinical signs:
- other: The results of the observations for gross signs of systemic toxicity noted throughout the study at the various dosage levels showed central nervous system depression, piloerection, and diarrhea were found in all animals and persisted up to four days in su
- Gross pathology:
- Gross necropsies performed at the termination of the study revealed no gross pathological alterations or lesions in any of the surviving animals.
- Interpretation of results:
- toxic
- Remarks:
- Migrated information Oral acute toxicity Cat 4 Criteria used for interpretation of results: EU
- Conclusions:
- Based on these results, the product tested (75 % C12-18-alkylbis(hydroxyethyl)methyl, chloride (CAS no 71808-53-2) and 25% water) is classfied as harmful by oral ingestion as that term is defined in the Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008.
Based on the concentration of the product, the same classification is valid for the active ingredient C12-18-alkylbis(hydroxyethyl)methyl, chloride (CAS no 71808-53-2). - Executive summary:
The study was conducted to evaluate the acute oral toxicity of the product (75 % C12 -18 -alkylbis(hydroxyethyl)methyl, chloride and 25% water)
according to US 16CFR 1500. The acute oral LD50 of the product tested was determined to be 1.71 g/kg bw. According to these regulations, the product would be considered harmful if swallowed.
Based on the concentration of the product, the same classification is valid for the active ingredient C12-18-alkylbis(hydroxyethyl)methyl, chloride (CAS no 71808-53-2). The acute oral LD50 of the active ingredient tested was determined to be >300 - 2000 mg/kg bw.
Label requirements under GHS: Symbol "Exclamation mark"; Signal word "Warning"; Hazard statement "Harmful if swallowed"
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 1 420 mg/kg bw
- Quality of whole database:
- In accordance with column 2 of REACH Annex VII, an acute oral toxicity study does not need to be conducted as the substance is classified as corrosive. Since two studies were already available, although with validity rating 2 and 3, the most recent performed study with the highest validity rating is used in order to classify the substance. Both the key study and the supporting study indicates GHS cat. 4 (LD50 between 300 and 2000 mg/kg).
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Oral
Two acute oral studies are available on C12-18-alkylbis(hydroxyethyl)methyl, chloride (CAS no 71808-53-2) are available. The newest with the highest validation rating is used as key study, even though it is stated incolumn 2 of REACH legislation Annex VII, that an acute oral toxicity study does not need to be conducted as the substance is classified as corrosive. Since two studies werealready available, although with validity rating 2 and 3, the most recent performed study with the highest validity rating is used in order to classify the substance. Both the key study and the supporting study indicates GHS cat. 4 (LD50 between 300 and 2000 mg/kg).
Inhalation
There is no study on inhalation toxicity available forC12-18-alkylbis(hydroxyethyl)methyl, chloride (CAS no 71808-53-2). REACH stipulates that testing by the inhalation route is appropriate if exposure of humans via inhalation is likely taking into account the vapour pressure of the substance and/or the possibility of exposure to aerosols, particles or droplets of an inhalable size. REACH guidance R.7.a, chapter. 7.4 Acute toxicity, indicates that in principle no inhalation studies are needed when vp < 0.1 Pa at 20°C or particle size > 100 µm. C12-14-diamine is a liquid with a vapour pressure of 0.00073 Pa at 20°C. Also the use of this substance will not result in aerosols, particles or droplets of an inhalable size, so exposure to humans via the inhalation route will be unlikely to occur, and no acute inhalation test was performed.
Dermal
There
is an old acute dermal toxicity study from 1958 available on
C12-18-alkylbis(hydroxyethyl)methyl, chloride (CAS no 71808-53-2). In
the study, all the animals died at the only tested dose level of 2.5
g/kg bw. The dermal LD50 value was therefore identified to be less than
2.5 g/kg bw. Due to the corrosive nature of the substance it is not
ethically justified to carry out another animal study to better identify
the LD50 value. In accordance with column 2 of REACH Annex VIII, an
acute skin toxicity study does not need to be conducted as the substance
is classified as corrosive to the skin.
Justification for classification or non-classification
Although the key acute oral study has a reliability of 2, it is considered to be correct and C12-18-alkylbis(hydroxyethyl)methyl, chloride (CAS no 71808-53-2) is classified for acute oral toxicity Category 4 based upon the classification criteria according to the Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008. Testing for acute dermal toxicity is not required in view of the corrosive properties of the substance and acute inhalational testing is also waived based on the physical/chemical properties of the substance as well as its corrosive properties.
Justification for selection of acute toxicity – oral endpoint
Appropriate study of the highest quality.
Justification for selection of acute toxicity – inhalation endpoint
In accordance with column 2 of REACH Annex VIII, an acute inhalation toxicity study does not need to be conducted as the substance is classified as corrosive. Neither is an inhalation study needed when vapour pressure is < 0.1 Pa at 20°C or particle size > 100 µm. C12-18-alkylbis(hydroxyethyl)methyl, chloride (CAS no 71808-53-2) is a handled as a liquid with a vapour pressure of 0.00073 Pa at 20°C and the identified uses are not expected to cause formation of aerosols, particles or droplets of inhalable size.
Justification for selection of acute toxicity – dermal endpoint
In accordance with column 2 of REACH Annex VIII, an acute skin toxicity study does not need to be conducted as the substance is classified as corrosive to the skin.
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
